Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs WINDLAS BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA WINDLAS BIOTECH BLISS GVS PHARMA/
WINDLAS BIOTECH
 
P/E (TTM) x 13.1 20.2 64.8% View Chart
P/BV x 1.3 2.7 50.5% View Chart
Dividend Yield % 0.4 0.8 56.9%  

Financials

 BLISS GVS PHARMA   WINDLAS BIOTECH
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
WINDLAS BIOTECH
Mar-23
BLISS GVS PHARMA/
WINDLAS BIOTECH
5-Yr Chart
Click to enlarge
High Rs91280 32.6%   
Low Rs67203 33.1%   
Sales per share (Unadj.) Rs72.2245.1 29.4%  
Earnings per share (Unadj.) Rs7.420.4 36.2%  
Cash flow per share (Unadj.) Rs9.226.3 34.9%  
Dividends per share (Unadj.) Rs0.504.00 12.5%  
Avg Dividend yield %0.61.7 38.1%  
Book value per share (Unadj.) Rs84.0190.9 44.0%  
Shares outstanding (eoy) m104.1520.93 497.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.11.0 111.6%   
Avg P/E ratio x10.811.9 90.8%  
P/CF ratio (eoy) x8.79.2 94.2%  
Price / Book Value ratio x0.91.3 74.6%  
Dividend payout %6.819.6 34.6%   
Avg Mkt Cap Rs m8,2625,055 163.4%   
No. of employees `000NANA-   
Total wages/salary Rs m862703 122.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,5165,131 146.5%  
Other income Rs m178100 178.5%   
Total revenues Rs m7,6945,230 147.1%   
Gross profit Rs m1,173602 194.8%  
Depreciation Rs m187124 151.0%   
Interest Rs m1048 1,315.2%   
Profit before tax Rs m1,061570 186.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m293144 203.5%   
Profit after tax Rs m767426 180.0%  
Gross profit margin %15.611.7 133.0%  
Effective tax rate %27.725.3 109.5%   
Net profit margin %10.28.3 122.9%  
BALANCE SHEET DATA
Current assets Rs m6,9743,535 197.3%   
Current liabilities Rs m1,9331,212 159.4%   
Net working cap to sales %67.145.3 148.1%  
Current ratio x3.62.9 123.7%  
Inventory Days Days39111 34.9%  
Debtors Days Days1,87183 2,250.0%  
Net fixed assets Rs m4,5621,734 263.0%   
Share capital Rs m104105 99.5%   
"Free" reserves Rs m8,6463,890 222.3%   
Net worth Rs m8,7503,995 219.1%   
Long term debt Rs m4071 37,330.3%   
Total assets Rs m11,5355,270 218.9%  
Interest coverage x11.273.4 15.3%   
Debt to equity ratio x00 17,041.8%  
Sales to assets ratio x0.71.0 66.9%   
Return on assets %7.68.2 91.6%  
Return on equity %8.810.7 82.2%  
Return on capital %12.714.5 87.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,618218 2,579.1%   
Fx outflow Rs m1,22568 1,802.1%   
Net fx Rs m4,394150 2,931.4%   
CASH FLOW
From Operations Rs m343610 56.3%  
From Investments Rs m-78-141 54.9%  
From Financial Activity Rs m-249-437 57.0%  
Net Cashflow Rs m3031 96.9%  

Share Holding

Indian Promoters % 35.0 62.8 55.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 13.1 168.1%  
FIIs % 15.4 1.4 1,137.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 37.2 174.9%  
Shareholders   40,758 61,900 65.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs WINDLAS BIOTECH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs WINDLAS BIOTECH Share Price Performance

Period BLISS GVS PHARMA WINDLAS BIOTECH S&P BSE HEALTHCARE
1-Day -1.31% -0.84% 1.18%
1-Month -9.12% 3.07% -0.75%
1-Year 58.26% 130.32% 61.82%
3-Year CAGR 3.89% 8.00% 18.16%
5-Year CAGR -8.75% 4.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the WINDLAS BIOTECH share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of WINDLAS BIOTECH the stake stands at 62.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of WINDLAS BIOTECH.

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

WINDLAS BIOTECH paid Rs 4.0, and its dividend payout ratio stood at 19.6%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of WINDLAS BIOTECH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.